NDC 68788-7161

Olanzapine

Olanzapine

Olanzapine is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Preferred Pharmaceuticals Inc.. The primary component is Olanzapine.

Product ID68788-7161_29809cd0-54b7-4ef8-807f-645c55912fe2
NDC68788-7161
Product TypeHuman Prescription Drug
Proprietary NameOlanzapine
Generic NameOlanzapine
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2018-06-05
Marketing CategoryANDA / ANDA
Application NumberANDA202862
Labeler NamePreferred Pharmaceuticals Inc.
Substance NameOLANZAPINE
Active Ingredient Strength5 mg/1
Pharm ClassesAtypical Antipsychotic [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 68788-7161-3

30 TABLET, FILM COATED in 1 BOTTLE (68788-7161-3)
Marketing Start Date2018-06-05
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68788-7161-3 [68788716103]

Olanzapine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA202862
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-06-05
Inactivation Date2020-01-31

NDC 68788-7161-6 [68788716106]

Olanzapine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA202862
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-06-05
Inactivation Date2020-01-31

NDC 68788-7161-9 [68788716109]

Olanzapine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA202862
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-06-05
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
OLANZAPINE5 mg/1

OpenFDA Data

SPL SET ID:5bded04a-d848-4ac6-b7c3-ff9b9fef3d29
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 312078
  • Pharmacological Class

    • Atypical Antipsychotic [EPC]

    NDC Crossover Matching brand name "Olanzapine" or generic name "Olanzapine"

    NDCBrand NameGeneric Name
    67877-175OlanzapineOlanzapine
    67877-174OlanzapineOlanzapine
    67877-172OlanzapineOlanzapine
    67877-173OlanzapineOlanzapine
    67877-176OlanzapineOlanzapine
    67877-177OlanzapineOlanzapine
    68084-529OlanzapineOlanzapine
    68084-723OlanzapineOlanzapine
    68084-528OlanzapineOlanzapine
    68084-740OlanzapineOlanzapine
    68084-525OlanzapineOlanzapine
    68258-7095OlanzapineOlanzapine
    68258-7152OlanzapineOlanzapine
    68258-7153OlanzapineOlanzapine
    68258-7154OlanzapineOlanzapine
    68382-365olanzapineolanzapine
    68382-368olanzapineolanzapine
    68258-7096OlanzapineOlanzapine
    68382-367olanzapineolanzapine
    68382-364olanzapineolanzapine
    68382-366olanzapineolanzapine
    68382-369olanzapineolanzapine
    68788-7161OlanzapineOlanzapine
    0517-0955OlanzapineOlanzapine
    69189-5510OlanzapineOlanzapine
    69543-384OlanzapineOlanzapine
    69543-380OlanzapineOlanzapine
    69543-381OlanzapineOlanzapine
    69543-383OlanzapineOlanzapine
    69543-382OlanzapineOlanzapine
    69543-385OlanzapineOlanzapine
    69807-2012OlanzapineOlanzapine
    69807-2011OlanzapineOlanzapine
    69807-2013OlanzapineOlanzapine
    70518-0026OlanzapineOlanzapine
    70518-0148OlanzapineOlanzapine
    70518-0145OlanzapineOlanzapine
    70518-0149OlanzapineOlanzapine
    70518-0314OlanzapineOlanzapine
    70518-0477OlanzapineOlanzapine
    70518-0110OlanzapineOlanzapine
    70518-0616OlanzapineOlanzapine
    70518-0144OlanzapineOlanzapine
    70518-0433OlanzapineOlanzapine
    70518-1206OlanzapineOlanzapine
    70518-0921OlanzapineOlanzapine
    70518-1207OlanzapineOlanzapine
    70518-0615OlanzapineOlanzapine
    70518-1115OlanzapineOlanzapine
    70518-1154OlanzapineOlanzapine

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.